171260 AMPK Inhibitor, Compound C - CAS 866405-64-3 - Calbiochem

171260
가격을 검색할 수 없습니다
Minimum Quantity needs to be mulitiple of
가격 문의 추가 정보
()이 할인됨
 
가격 문의
재고 없음재고 없음
예상 출고 가능일 
단종품
제한된 수량 가능
재고여부 확인
    Remaining: will advise
      Remaining: will advise
      추천사항
      고객 서비스로 문의
      Contact Customer Service
      가격 및 재고 조회

      개요

      Replacement Information

      주요 사양표

      Empirical FormulaCAS #
      C₂₄H₂₅N₅O 866405-64-3

      가격 및 재고여부

      카탈로그 번호 재고 정보패킹 포장 단위 가격(VAT 별도) 수량
      171260-10MGCN
      재고 정보 검색...
      재고 없음재고 없음
      예상 출고 가능일 
      단종품
      제한된 수량 가능
      재고여부 확인
        Remaining: will advise
          Remaining: will advise
          추천사항
          고객 서비스로 문의
          Contact Customer Service

          Plastic ampoule 10 mg
          가격 검색...
          가격을 검색할 수 없습니다
          Minimum Quantity needs to be mulitiple of
          가격 문의 추가 정보
          ()이 할인됨
           
          가격 문의
          171260-1MGCN
          재고 정보 검색...
          재고 없음재고 없음
          예상 출고 가능일 
          단종품
          제한된 수량 가능
          재고여부 확인
            Remaining: will advise
              Remaining: will advise
              추천사항
              고객 서비스로 문의
              Contact Customer Service

              Plastic ampoule 1 mg
              가격 검색...
              가격을 검색할 수 없습니다
              Minimum Quantity needs to be mulitiple of
              가격 문의 추가 정보
              ()이 할인됨
               
              가격 문의
              171260-5MGCN
              재고 정보 검색...
              재고 없음재고 없음
              예상 출고 가능일 
              단종품
              제한된 수량 가능
              재고여부 확인
                Remaining: will advise
                  Remaining: will advise
                  추천사항
                  고객 서비스로 문의
                  Contact Customer Service

                  Plastic ampoule 5 mg
                  가격 검색...
                  가격을 검색할 수 없습니다
                  Minimum Quantity needs to be mulitiple of
                  가격 문의 추가 정보
                  ()이 할인됨
                   
                  가격 문의
                  Description
                  OverviewA cell-permeable pyrrazolopyrimidine compound that inhibits against KDR/VEGFR2, ALK2/BMPR-I, AMPK kinase activity (IC50 = 25.1, 148, and 234.6 nM, respectively), while exhibiting much reduced or little effect toward ALK5/TGFβR-I, ZAPK, Syk, PKCθ, PKA, or JAK3. Shown to block both BMP pathway-dependent dorsoventral development (EC100 = 2.5 µM) and VEGF signaling-dependent intersomitic vessel formation (EC50 = 5 µM) in zebrafish embryo in vivo. Commonly used in combination with AMPK activators AICAR (Cat. No. 123040) and/or Metformin (Cat. No. 317240) for studying AMPK-dependent cellular events in vitro and physiological responses in animals in vivo. Also available as a 10 mM solution in DMSO (Cat. No. 171261).
                  Catalogue Number171260
                  Brand Family Calbiochem®
                  Synonyms6-[4-(2-Piperidin-1-yl-ethoxy)-phenyl)]-3-pyridin-4-yl-pyrrazolo[1,5-a]-pyrimidine, Dorsomorphin, AMPK Inhibitor I, BMP Inhibitor I
                  References
                  ReferencesHao, J., et al. 2010. ACS Chem.Biol. 5, 245.
                  Yu, P.B., et al. 2008. Nat. Chem. Biol 4, 33.
                  Kim, E.K., et al. 2004. J. Biol. Chem. 279, 19970.
                  Lee, M., et al. 2003. J. Biol. Chem. 278, 39653.
                  Inoki, K., et al. 2003. Cell 115, 577.
                  Fryer, L.G., 2002. FEBS Lett. 531, 189.
                  Zhou, G., et al. 2001. J. Clin. Invest. 108, 1167.
                  Product Information
                  CAS number866405-64-3
                  ATP CompetitiveY
                  FormLight yellow solid
                  Hill FormulaC₂₄H₂₅N₅O
                  Chemical formulaC₂₄H₂₅N₅O
                  ReversibleY
                  Structure formula ImageStructure formula Image
                  Quality LevelMQ100
                  Applications
                  Biological Information
                  Primary TargetAMPK
                  Primary Target IC<sub>50</sub>25.1, 148, and 234.6 nM, against KDR/VEGFR2, ALK2/BMPR-I, AMPK kinase activity, respectively
                  Primary Target K<sub>i</sub>EC100 = 2.5 µM against BMP pathway-dependent dorsoventral development; EC50 = 5 µM against VEGF signaling-dependent intersomitic vessel formation in zebrafish embryo in vivo
                  Purity≥95% by HPLC
                  Physicochemical Information
                  Cell permeableY
                  Dimensions
                  Materials Information
                  Toxicological Information
                  Safety Information according to GHS
                  Safety Information
                  Product Usage Statements
                  Storage and Shipping Information
                  Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
                  Toxicity Standard Handling
                  Storage +2°C to +8°C
                  Protect from Light Protect from light
                  Do not freeze Ok to freeze
                  Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
                  Packaging Information
                  Packaged under inert gas Packaged under inert gas
                  Transport Information
                  Supplemental Information
                  Specifications

                  Documentation

                  AMPK Inhibitor, Compound C - CAS 866405-64-3 - Calbiochem MSDS

                  타이틀

                  물질안전보건자료(MSDS) 

                  AMPK Inhibitor, Compound C - CAS 866405-64-3 - Calbiochem Certificates of Analysis

                  TitleLot Number
                  171260

                  References

                  참고문헌 보기
                  Hao, J., et al. 2010. ACS Chem.Biol. 5, 245.
                  Yu, P.B., et al. 2008. Nat. Chem. Biol 4, 33.
                  Kim, E.K., et al. 2004. J. Biol. Chem. 279, 19970.
                  Lee, M., et al. 2003. J. Biol. Chem. 278, 39653.
                  Inoki, K., et al. 2003. Cell 115, 577.
                  Fryer, L.G., 2002. FEBS Lett. 531, 189.
                  Zhou, G., et al. 2001. J. Clin. Invest. 108, 1167.
                  Data Sheet

                  Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

                  Revision22-March-2012 JSW
                  Synonyms6-[4-(2-Piperidin-1-yl-ethoxy)-phenyl)]-3-pyridin-4-yl-pyrrazolo[1,5-a]-pyrimidine, Dorsomorphin, AMPK Inhibitor I, BMP Inhibitor I
                  DescriptionA cell-permeable pyrrazolopyrimidine compound that inhibits against KDR/VEGFR2, ALK2/BMPR-I, AMPK kinase activity (IC50 = 25.1, 148, and 234.6 nM, respectively), while exhibiting much reduced or little effect toward ALK5/TGFβR-I, ZAPK, Syk, PKCθ, PKA, or JAK3. Shown to block both BMP pathway-dependent dorsoventral development (EC100 = 2.5 µM) and VEGF signaling-dependent intersomitic vessel formation (EC50 = 5 µM) in zebrafish embryo in vivo. Commonly used in combination with AMPK activators AICAR (Cat. No. 123040) and/or Metformin (Cat. No. 317240) for studying AMPK-dependent cellular events in vitro and physiological responses in animals in vivo. Also available as a 10 mM solution in DMSO (Cat. No. 171261).
                  FormLight yellow solid
                  Intert gas (Yes/No) Packaged under inert gas
                  CAS number866405-64-3
                  Chemical formulaC₂₄H₂₅N₅O
                  Structure formulaStructure formula
                  Purity≥95% by HPLC
                  SolubilityDMSO (4 mg/ml), 2% HCl (10 mg/ml), 2% Acetic Acid (10 mg/ml), or Methanol (3 mg/ml)
                  Storage +2°C to +8°C
                  Protect from light
                  Do Not Freeze Ok to freeze
                  Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
                  Toxicity Standard Handling
                  ReferencesHao, J., et al. 2010. ACS Chem.Biol. 5, 245.
                  Yu, P.B., et al. 2008. Nat. Chem. Biol 4, 33.
                  Kim, E.K., et al. 2004. J. Biol. Chem. 279, 19970.
                  Lee, M., et al. 2003. J. Biol. Chem. 278, 39653.
                  Inoki, K., et al. 2003. Cell 115, 577.
                  Fryer, L.G., 2002. FEBS Lett. 531, 189.
                  Zhou, G., et al. 2001. J. Clin. Invest. 108, 1167.